SCAI TAVR CENTER features a variety of resources aimed at helping interventional cardiologists become proficient in transcatheter aortic replacement (TAVR).
As TAVR was recently approved in the United States, SCAI understands that there is a wide spectrum of educational need within the interventional community. Our goal through this page is to address TAVR from those at the beginner level all the way up to our colleagues at an advanced training level.
SCAI WIN TAVI Registry Hits Half-Way Point
The SCAI WIN TAVI Registry, an all-female data registry organized by the SCAI Women in Innovations (WIN) initiative, has hit the half-way point at 500 patients enrolled. With a goal of 1,000 patients, the project has recruited 17 study sites in Europe to volunteer their participation, with several Canadian sites preparing to join. MORE
Sapien XT Valve Cleared by FDA
MedPage Today: Treatment options for patients with severe symptomatic aortic stenosis continue to expand with the FDA's approval of the second-generation Sapien XT transcatheter heart valve. READ THE ARTICLE
RELATED: Dr. Kreton Mavromatis Discusses Key Points of FDA Approval of SAPIEN XT
Ramesh Daggubati, MD, FSCAI compares balloon-expandable vs. self-expandable valves in patients undergoing transcatheter aortic valve replacement and the CHOICE Randomized Clinical Trial. VIEW IT NOW
TAVR Image Review
Guiding transapical access around epicardial collaterals. REVIEW